Matthew Harrison
Stock Analyst at Morgan Stanley
(3.50)
# 836
Out of 5,170 analysts
712
Total ratings
49.19%
Success rate
3.9%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LEGN Legend Biotech | Maintains: Overweight | $50 → $49 | $17.87 | +174.20% | 15 | Mar 11, 2026 | |
| R Ryder System | Maintains: Positive | $235 → $250 | $192.47 | +29.89% | 2 | Feb 13, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Equal-Weight | $768 → $769 | $737.45 | +4.28% | 59 | Feb 2, 2026 | |
| INSM Insmed | Maintains: Equal-Weight | $157 → $162 | $144.00 | +12.50% | 20 | Jan 30, 2026 | |
| GILD Gilead Sciences | Maintains: Overweight | $151 → $150 | $141.11 | +6.30% | 44 | Jan 13, 2026 | |
| MRNA Moderna | Maintains: Equal-Weight | $30 → $28 | $52.37 | -46.53% | 27 | Dec 12, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $149 → $156 | $183.41 | -14.94% | 56 | Dec 12, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $1,070 → $1,110 | $684.50 | +62.16% | 27 | Dec 4, 2025 | |
| PHVS Pharvaris | Maintains: Overweight | $37 → $41 | $26.13 | +56.91% | 16 | Dec 4, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Equal-Weight | $8 → $4 | $2.56 | +56.25% | 5 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $98 | $55.03 | +78.08% | 23 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $33 → $30 | $19.75 | +51.90% | 13 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $4 | $0.19 | +2,005.26% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $460 → $439 | $458.05 | -4.16% | 41 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $20 | $16.65 | +20.12% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $6.00 | - | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $0.80 | +522.12% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $32.04 | +74.78% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $28.98 | +89.79% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $2.06 | +45.63% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $28.34 | -61.19% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.35 | +197.87% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $25.73 | +24.37% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.68 | +416.30% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $1.45 | -31.03% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $22.09 | -54.73% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $7.04 | +13.64% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $32.53 | +35.26% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $3.17 | +310.09% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $20.77 | +285.17% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $4.54 | +1,221.59% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $89.31 | +141.85% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $4.04 | +23.76% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $3.69 | +35.50% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $206.23 | -11.75% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $22.67 | -60.29% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $349.92 | -19.41% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $311.10 | -32.50% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $27.41 | +89.71% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $237.60 | -27.19% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $20.42 | +487.66% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $8.96 | +1,551.79% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $114.20 | -28.20% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $58.11 | +13.58% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $4.56 | +755.26% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $45.53 | +1.03% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $6.27 | +458.21% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $917.50 | -70.03% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.93 | +548.46% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $8.36 | +641.63% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $15.17 | +13.71% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $92.95 | -10.70% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $62.95 | -84.11% | 4 | Sep 10, 2018 |
Legend Biotech
Mar 11, 2026
Maintains: Overweight
Price Target: $50 → $49
Current: $17.87
Upside: +174.20%
Ryder System
Feb 13, 2026
Maintains: Positive
Price Target: $235 → $250
Current: $192.47
Upside: +29.89%
Regeneron Pharmaceuticals
Feb 2, 2026
Maintains: Equal-Weight
Price Target: $768 → $769
Current: $737.45
Upside: +4.28%
Insmed
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $157 → $162
Current: $144.00
Upside: +12.50%
Gilead Sciences
Jan 13, 2026
Maintains: Overweight
Price Target: $151 → $150
Current: $141.11
Upside: +6.30%
Moderna
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $30 → $28
Current: $52.37
Upside: -46.53%
Biogen
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $149 → $156
Current: $183.41
Upside: -14.94%
argenx SE
Dec 4, 2025
Maintains: Overweight
Price Target: $1,070 → $1,110
Current: $684.50
Upside: +62.16%
Pharvaris
Dec 4, 2025
Maintains: Overweight
Price Target: $37 → $41
Current: $26.13
Upside: +56.91%
Zentalis Pharmaceuticals
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $8 → $4
Current: $2.56
Upside: +56.25%
Oct 28, 2025
Maintains: Overweight
Price Target: $104 → $98
Current: $55.03
Upside: +78.08%
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $19.75
Upside: +51.90%
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.19
Upside: +2,005.26%
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $458.05
Upside: -4.16%
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $16.65
Upside: +20.12%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $6.00
Upside: -
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.80
Upside: +522.12%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $32.04
Upside: +74.78%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $28.98
Upside: +89.79%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $2.06
Upside: +45.63%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $28.34
Upside: -61.19%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.35
Upside: +197.87%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $25.73
Upside: +24.37%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.68
Upside: +416.30%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $1.45
Upside: -31.03%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $22.09
Upside: -54.73%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $7.04
Upside: +13.64%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $32.53
Upside: +35.26%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $3.17
Upside: +310.09%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $20.77
Upside: +285.17%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $4.54
Upside: +1,221.59%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $89.31
Upside: +141.85%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.04
Upside: +23.76%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $3.69
Upside: +35.50%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $206.23
Upside: -11.75%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $22.67
Upside: -60.29%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $349.92
Upside: -19.41%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $311.10
Upside: -32.50%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $27.41
Upside: +89.71%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $237.60
Upside: -27.19%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $20.42
Upside: +487.66%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $8.96
Upside: +1,551.79%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $114.20
Upside: -28.20%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $58.11
Upside: +13.58%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $4.56
Upside: +755.26%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $45.53
Upside: +1.03%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $6.27
Upside: +458.21%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $917.50
Upside: -70.03%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.93
Upside: +548.46%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $8.36
Upside: +641.63%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $15.17
Upside: +13.71%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $92.95
Upside: -10.70%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $62.95
Upside: -84.11%